Pages that link to "Q42710017"
Jump to navigation
Jump to search
The following pages link to Lars F. Berglund (Q42710017):
Displaying 50 items.
- Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline (Q24608464) (← links)
- High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men (Q28140311) (← links)
- Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia (Q28256835) (← links)
- Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population (Q28344927) (← links)
- Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS) (Q30224653) (← links)
- Obesity and lifespan health--importance of the fetal environment (Q33570518) (← links)
- Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis (Q33639909) (← links)
- Postprandial lipoproteins and cardiovascular disease risk in diabetes mellitus (Q33651279) (← links)
- Reengineering the national clinical and translational research enterprise: the strategic plan of the National Clinical and Translational Science Awards Consortium (Q33692929) (← links)
- Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians (Q33849524) (← links)
- Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans (Q33892999) (← links)
- Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population (Q34037051) (← links)
- Sustained effects of a nurse coaching intervention via telehealth to improve health behavior change in diabetes (Q34103795) (← links)
- The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis. (Q34215047) (← links)
- Influence of age on the metabolism of plasma low density lipoproteins in healthy males (Q34237195) (← links)
- Usefulness of apolipoprotein B/apolipoprotein A-I ratio to predict coronary artery disease independent of the metabolic syndrome in African Americans (Q34288900) (← links)
- Studies with the haeme oxygenase inhibitor Sn-protoporphyrin in patients with primary biliary cirrhosis and idiopathic haemochromatosis (Q34392729) (← links)
- Purification and characterization of pig kidney pyruvate kinase (type A) (Q34408427) (← links)
- Apolipoprotein E and diets: a case of gene-nutrient interaction? (Q34493747) (← links)
- Comparison of C-reactive protein and metabolic syndrome as cardiovascular risk factors in African-Americans and European-Americans (Q34636050) (← links)
- Increased stroke risk and lipoprotein(a) in a multiethnic community: the Northern Manhattan Stroke Study (Q34724879) (← links)
- Enigmatic role of lipoprotein(a) in cardiovascular disease (Q34786504) (← links)
- HIV protease inhibitors and obesity (Q34792983) (← links)
- Integrated role of two apoliprotein E polymorphisms on apolipoprotein B levels and coronary artery disease in a biethnic population (Q35075040) (← links)
- Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions (Q35080372) (← links)
- Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease (Q35104006) (← links)
- Relationship of postprandial nonesterified fatty acids, adipokines, and insulin across gender in human immunodeficiency virus-positive patients undergoing highly active antiretroviral therapy (Q35104013) (← links)
- Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians (Q35109551) (← links)
- Age as a modulator of inflammatory cardiovascular risk factors (Q35171257) (← links)
- Diverging trajectory patterns of systemic versus vascular inflammation over age in healthy Caucasians and African-Americans (Q35181453) (← links)
- Increased concentrations of serum lipoprotein (a) in response to growth hormone treatment (Q35188880) (← links)
- Attenuated age-impact on systemic inflammatory markers in the presence of a metabolic burden (Q35225272) (← links)
- Postprandial lipemia and cardiovascular disease (Q35549906) (← links)
- Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk (Q35575772) (← links)
- Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks (Q35597938) (← links)
- Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma (Q35600471) (← links)
- Rhesus monkey (Macaca mulatta) lipoprotein(a) and apolipoprotein(a): high frequency of small size apolipoprotein(a) isoforms (Q35602654) (← links)
- Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women (Q35656105) (← links)
- Lipoprotein(a): an elusive cardiovascular risk factor (Q35746190) (← links)
- Effects of estrogen on low density lipoprotein metabolism in males. Short-term and long-term studies during hormonal treatment of prostatic carcinoma (Q35814099) (← links)
- HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels (Q35958319) (← links)
- Linking scientific discovery and better health for the nation: the first three years of the NIH's Clinical and Translational Science Awards (Q36003338) (← links)
- Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk. (Q36074792) (← links)
- Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans (Q36295250) (← links)
- High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans (Q36536773) (← links)
- Lipoprotein(a) and thrombocytes: potential mechanisms underlying cardiovascular risk (Q36551318) (← links)
- Increased lipoprotein remnant cholesterol levels in HIV-positive patients during antiretroviral therapy (Q36616941) (← links)
- Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome (Q36653816) (← links)
- Lipoprotein(a): a unique risk factor for cardiovascular disease. (Q36655571) (← links)
- Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a). (Q36696683) (← links)